HOME >> MEDICINE >> NEWS
Carnegie Mellon receives grant to study security issues

PITTSBURGH-- Carnegie Mellon University's Department of Engineering and Public Policy (EPP) received a five-year, $2 million grant from the John D. and Catherine T. MacArthur Foundation to support a variety of security-related research projects.

Granger Morgan, head of EPP, said the grant will support a wide range of research projects on issues related to security and engineered civil systems, including improved communication among emergency responders, decontamination after a dirty bomb or chemical attack, vulnerability of computer, electric power and water systems, and how to involve the public in key decision making.

"Much as we might like to do it, preventing all attacks everywhere is just not possible," said Morgan. "What we can do is dramatically reduce our vulnerabilities and look for ways that we can achieve other important social goals, such as improved public health." Morgan also said that identifying and improving the balance among legitimate conflicting public interests will be an important objective of the work.

In Ph.D. research recently completed and supported by the MacArthur Foundation, Matt Dombroski, who now works for the Lawrence Livermore National Laboratory, did careful modeling of the implications of a dirty bomb attack in downtown Pittsburgh. Building on his technical analysis, Dombroski studied the implications of alternative communication about evacuation or sheltering in place for different attack scenarios, according to Morgan.

Other recent security work conducted by EPP faculty and students has included analysis of how best to detect and limit the impacts of biological attacks, how to make the electric power system more secure, and how to limit the loss of privacy and anonymity in a world with wide-spread computer monitoring and massive data bases.


'"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
16-Jan-2006


Page: 1

Related medicine news :

1. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
2. Carnegie Mellon professors question advice for nuclear attacks
3. Carnegie Mellon researcher wins prestigious career award for NSF
4. Study by Childrens Hospital and Carnegie Mellon explains crucial deficit in children with autism
5. Carnegie Mellon receives NIMH/NSF grant to examine mechanisms that underlie neuronal synchronization
6. Carnegie Mellon, Ohio State get grant to study link between antidepressants and suicidality in teens
7. Carnegie Mellon study demonstrates that lower income, education lead to greater stress levels
8. Carnegie Mellon researchers say use of switchgrass could solve energy woes
9. Teens unaware of sexually transmitted diseases until they catch one, Carnegie Mellon study finds
10. Carnegie Mellon, Pitt demo technology to help elderly at CAST exhibition in Washington
11. Carnegie Mellon psychologist receives NIH grant

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Carnegie Mellon receives grant study security issues

(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: